Jesse Erin, Thirumavalavan Nannan, Loeb Aram
Urology Institute, University Hospitals Cleveland Medical Center Case Western Reserve University, 11100 Euclid Avenue Lakeside Building Suite, Cleveland, OH 4954 USA.
Curr Sex Health Rep. 2022;14(4):119-127. doi: 10.1007/s11930-022-00332-z. Epub 2022 Aug 5.
Direct-to-consumer telemedicine has vastly expanded in recent years, and urologic conditions are a common target for these companies. We aim to identify the urologic conditions being treated by direct-to-consumer telemedicine platforms and review the feasibility of adherence to evidence-based practice guidelines via this relatively new healthcare model.
Erectile dysfunction, premature ejaculation, testosterone deficiency, and male infertility are being treated with direct-to-consumer telemedicine. Such platforms treating erectile dysfunction perform modestly in practice guideline adherence. Guidelines-based treatment of other urologic conditions via telemedicine is feasible, however, the treatment of these conditions through popular direct-to-consumer telemedicine platforms is largely unstudied.
The impact of direct-to-consumer telemedicine on the field of urology is vast and likely to continue to grow. Future studies should inspect direct-to-consumer telemedicine companies' practice patterns and treatment outcomes to ensure the field's standards of care are being met. Guidelines specific to the treatment of various urologic conditions via telemedicine are needed.
近年来，直接面向消费者的远程医疗发展迅速，泌尿科疾病是这些公司的常见治疗目标。我们旨在确定直接面向消费者的远程医疗平台所治疗的泌尿科疾病，并探讨通过这种相对较新的医疗模式遵循循证实践指南的可行性。
直接面向消费者的远程医疗正在治疗勃起功能障碍、早泄、睾酮缺乏和男性不育症。此类治疗勃起功能障碍的平台在遵循实践指南方面表现一般。通过远程医疗基于指南治疗其他泌尿科疾病是可行的，然而，通过流行的直接面向消费者的远程医疗平台治疗这些疾病在很大程度上尚未得到研究。
直接面向消费者的远程医疗对泌尿外科领域的影响巨大，且可能会持续增长。未来的研究应检查直接面向消费者的远程医疗公司的实践模式和治疗结果，以确保达到该领域的护理标准。需要针对通过远程医疗治疗各种泌尿科疾病的特定指南。
